Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$537K Buy
7,456
+1,121
+18% +$78K 0.02% 698
2020
Q1
$363K Buy
6,335
+2,207
+53% +$204K 0.01% 727
2019
Q4
$462K Buy
4,128
+267
+7% +$28.5K 0.01% 734
2019
Q3
$371K Buy
3,861
+277
+8% +$26K 0.01% 766
2019
Q2
$307K Sell
3,584
-1,997
-36% -$164K 0.01% 813
2019
Q1
$464K Buy
+5,581
New +$405K 0.02% 698

Other funds holding CNMD

Brinker Capital's CNMD Position: Q2 2020 in Review

Brinker Capital increased its CONMED (CNMD) stake by 18% in Q2 2020, buying an estimated $78K and bringing the position to 7,456 shares worth $537K. The position accounts for 0.02% of the portfolio, ranked #698.

Brinker Capital first reported a position in CNMD in Q1 2019 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CNMD as of Q2 2020.

  • Brinker Capital held 7,456 shares of CONMED worth $537K as of Q2 2020.
  • Brinker Capital bought 1,121 CONMED shares in Q2 2020, an estimated $78K.
  • CONMED made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #698 holding.
  • Brinker Capital first reported a position in CONMED in Q1 2019 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CONMED as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.